The Global Oxidative Stress Assay Market size is expected to reach $2 billion by 2030, rising at a market growth of 9.4% CAGR during the forecast period.
The high prevalence of chronic diseases in North America drives the demand for oxidative stress assays. Thus, the North America region acquired 36.5% revenue share in the market 2022. According to the Centers for Disease Control and Prevention, six out of ten Americans suffer from at least one chronic condition, including diabetes, cancer, heart disease, or a stroke. The leading causes of death and disability in the US are these and other chronic disorders, dramatically raising healthcare costs.
Preventive healthcare involves early detection and intervention to address potential health issues before they progress. Oxidative stress assays are critical for early detection of oxidative damage, allowing healthcare providers to act proactively and avoid disease progression.
Additionally, according to the World Health Organization, one in six people will be 60 or older by 2030. The number of people 60 and older in the world will increase from 1 billion in 2020 to 1.4 billion in 2050. By 2050, there will be 2.1 billion people in the world who are 60 or older. It is anticipated that there will be 426 million persons 80 or older by 2050.
However, the intricate nature of oxidative stress pathways makes developing assays specifically targeting individual pathways challenging. Due to the multitude of interconnected pathways involved, assays may struggle to provide a comprehensive understanding of this. Thus, complexity of oxidative stress pathways can slow down the growth of the market.
The high prevalence of chronic diseases in North America drives the demand for oxidative stress assays. Thus, the North America region acquired 36.5% revenue share in the market 2022. According to the Centers for Disease Control and Prevention, six out of ten Americans suffer from at least one chronic condition, including diabetes, cancer, heart disease, or a stroke. The leading causes of death and disability in the US are these and other chronic disorders, dramatically raising healthcare costs.
Preventive healthcare involves early detection and intervention to address potential health issues before they progress. Oxidative stress assays are critical for early detection of oxidative damage, allowing healthcare providers to act proactively and avoid disease progression.
Additionally, according to the World Health Organization, one in six people will be 60 or older by 2030. The number of people 60 and older in the world will increase from 1 billion in 2020 to 1.4 billion in 2050. By 2050, there will be 2.1 billion people in the world who are 60 or older. It is anticipated that there will be 426 million persons 80 or older by 2050.
However, the intricate nature of oxidative stress pathways makes developing assays specifically targeting individual pathways challenging. Due to the multitude of interconnected pathways involved, assays may struggle to provide a comprehensive understanding of this. Thus, complexity of oxidative stress pathways can slow down the growth of the market.
By Disease Type Analysis
By disease type, the market is categorized into cardiovascular disease, respiratory diseases, cancer, diabetes, and others. The respiratory diseases segment garnered 25.2% revenue share in the market in 2022.By End User Analysis
Based on end-user, the market is classified into pharmaceutical & biotechnology industries, academic research institutes, contract research organizations, clinical laboratories, and others. In 2022, the pharmaceutical & biotechnology industries segment captured 36.4% revenue share in the market.By Product Analysis
By product, the market is categorized into instruments, consumables, and services. The consumables segment covered 45.2% revenue share in the market in 2022. Consumables are designed to be user-friendly and convenient. Researchers and clinicians benefit from ready-to-use kits and reagents that simplify experimental workflows.
By Test Type Analysis
Based on test type, the market is classified into indirect assays, antioxidant capacity assays, enzyme-based assays, and reactive oxygen species-based assays. The antioxidant capacity assays segment recorded 22.9% revenue share in the market in 2022.By Technology Analysis
On the basis of technology, the market is divided into enzyme-linked immunosorbent assay (ELISA), flow cytometry, chromatography, microscopy, and others. In 2022, the enzyme-linked immunosorbent assay (ELISA) segment held 37.2% revenue share in the market.By Regional Analysis
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired 36.5% revenue share in the market. In Asia-Pacific, these are in high demand because of the increasing prevalence of chronic diseases.List of Key Companies Profiled
- Abcam Plc (Danaher Corporation)
- Merck KGaA
- Promega Corporation
- Qiagen N.V
- Thermo Fisher Scientific, Inc.
- Cayman Chemical Company, Inc.
- AMS Biotechnology (Europe) Limited.
- Cell Biolabs, Inc.
- Enzo Life Sciences, Inc. (Enzo Biochem, Inc.)
- ImmunoChemistry Technologies
Market Report Segmentation
By Product- Consumables
- Instruments
- Services
- Indirect Assays
- Antioxidant Capacity Assays
- Enzyme-Based Assays
- Reactive Oxygen Species-Based Assays
- Enzyme-linked Immunosorbent Assay (ELISA)
- Flow Cytometry
- Chromatography
- Microscopy
- Others
- Cardiovascular Disease
- Respiratory Diseases
- Cancer
- Diabetes
- Others
- Pharmaceutical & Biotechnology Industries
- Contract Research Organizations
- Academic Research Institutes
- Clinical Laboratories
- Others
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Global Oxidative Stress Assay Market by Product
Chapter 5. Global Oxidative Stress Assay Market by Test Type
Chapter 6. Global Oxidative Stress Assay Market by Technology
Chapter 7. Global Oxidative Stress Assay Market by Disease Type
Chapter 8. Global Oxidative Stress Assay Market by End-user
Chapter 9. Global Oxidative Stress Assay Market by Region
Chapter 10. Company Profiles
Companies Mentioned
- Abcam Plc (Danaher Corporation)
- Merck KGaA
- Promega Corporation
- Qiagen N.V
- Thermo Fisher Scientific, Inc.
- Cayman Chemical Company, Inc.
- AMS Biotechnology (Europe) Limited.
- Cell Biolabs, Inc.
- Enzo Life Sciences, Inc. (Enzo Biochem, Inc.)
- ImmunoChemistry Technologies
Methodology
LOADING...
